Cutler Group LLC / CA - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
3,2200.0%0.00%
Q2 2023$1
-50.0%
3,2200.0%0.00%
Q1 2023$2
-33.3%
3,220
-8.5%
0.00%
Q4 2022$3
-99.8%
3,5200.0%0.00%
Q3 2022$2,000
+100.0%
3,5200.0%0.00%
Q2 2022$1,000
-85.7%
3,5200.0%0.00%
Q1 2022$7,000
-88.9%
3,520
-83.1%
0.00%
-100.0%
Q4 2021$63,000
-64.0%
20,819
-53.9%
0.00%
-71.4%
Q3 2021$175,00045,1510.01%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders